Financial Statements

AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Corporation (APHB)


Balance Sheet Statement

Download APHB income statement Download APHB income statement
Year 2012201320142015201620172018
Cash and cash equivalents 0.8620.366.589.375.715.138.16
Short-term investments -------
Cash and short-term investments 0.8620.366.589.375.715.138.16
Inventories -------
Property, Plant & Equipment Net
Goodwill and Intangible Assets 20.287.967.9312.7810.77--
Long-term investments -------
Tax assets 0.62------
Total non-current assets 3.0860.7421.324.504.891.440.84
Total current assets 20.4220.5521.6021.4811.845.753.48
Total assets 22.0741.2128.6231.4918.1511.1411.89
Payables 1.942.
Short-term debt 3.65------
Total current liabilities 6.052.391.872.383.541.972.57
Long-term debt -------
Total debt 3.65---0.80--
Deferred revenue -
Tax Liabilities -------
Deposit Liabilities -------
Total non-current liabilities 3.0860.7421.324.504.891.440.84
Total liabilities 9.1363.1323.195.408.433.413.41
Other comprehensive income -------
Retained earnings (deficit) -320.53-385.12-362.01-362.52-381.36-394.21-406.32
Total shareholders equity 12.94-22.633.4412.719.727.738.47
Investments -------
Net Debt 2.79-20.36-6.58-9.37-5.71-5.13-8.16
Other Assets 0.770.300.340.520.600.250.25
Other Liabilities 0.470.240.701.342.481.391.84

AmpliPhi Biosciences Corporation income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AmpliPhi Biosciences Corporation FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.